• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC; CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC; CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Model Number N/A
Device Problem Leak/Splash (1354)
Patient Problem Burn(s) (1757)
Event Type  Injury  
Event Description
Five patients were receiving continuous titrated infusion of calcium chloride (cacl) in the pediatric intensive care unit (picu).The patient's were receiving extracorporeal membrane oxygenation (ecmo) and/or continuous renal replacement therapies (crrt) through a femoral central venous catheter when the user facility experienced difficulty.It was reported that a few days into use of the central venous catheters the clinician noticed burns at the insertion sites in al five patients.It was discovered that there had been infiltration/extravasation of the cacl infusate.The infusion was discontinued.The wounds were treated.Certain cases required interventional procedures with a vascular surgeon and/or plastic surgeon.
 
Manufacturer Narrative
(b)(4).The event is currently under investigation.
 
Manufacturer Narrative
Cook spectrum minocycline/rifampin impregnated triple lumen central venous catheter tray.(b)(4).Event evaluation a review of the complaint history, manufacturing instructions (mi), quality control (qc), functional testing and a visual inspection of the complaint device was conducted for the purpose of this investigation.One device was returned in an open and used condition.Upon inspection, the tip of the catheter is coated in a white substance, most likely from the calcium chloride infusate.The distance between the sideports and catheter tip was measured to verify that it met specification.The catheter was clamped just above the side ports and injected with water to verify there were no leaks in the hub or shaft.No anomalies were found.Inspection indicates the returned device was made to specification.This is the only reported complaint for infiltration/extravasation of infuscate.Based on this evaluation, no conclusion could be drawn.We will continue to monitor for similar complaints and have notified the appropriate internal personnel.
 
Event Description
Five patients were receiving continuous titrated infusion of calcium chloride (cacl) in the pediatric intensive care unit (picu).The patient's were receiving extracorporeal membrane oxygenation (ecmo) and/or continuous renal replacement therapies (crrt) through a femoral central venous catheter when the user facility experienced difficulty.It was reported that a few days into use of the central venous catheters the clinician noticed burns at the insertion sites in all five patients.It was discovered that there had been infiltration/extravasation of the cacl infusate.The infusion was discontinued.The wounds were treated.Certain cases required interventional procedures with a vascular surgeon and/or plastic surgeon.
 
Manufacturer Narrative
Cook spectrum minocycline/rifampin impregnated triple lumen central venous catheter tray.Foz catheter, intravascular, therapeutic, short-term less than 30 days.Lot # not provided by reporter.Catalog # not provided by reporter.Expiration date unknown as lot # is unknown.Udi # unknown as lot # is unknown.(b)(4).
 
Event Description
Five patients were receiving continuous titrated infusion of calcium chloride (cacl) in the pediatric intensive care unit (picu).The patient's were receiving extracorporeal membrane oxygenation (ecmo) and/or continuous renal replacement therapies (crrt) through a femoral central venous catheter when the user facility experienced difficulty.It was reported that a few days into use of the central venous catheters the clinician noticed burns at the insertion sites in all five patients.It was discovered that there had been infiltration/extravasation of the cacl infusate.The infusion was discontinued.The wounds were treated.Certain cases required interventional procedures with a vascular surgeon and/or plastic surgeon.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK
Type of Device
CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer Contact
larry pool
750 daniels way
bloomington, IN 47404
8123392235
MDR Report Key4808061
MDR Text Key15566569
Report Number1820334-2015-00325
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative
Reporter Occupation Other
Type of Report Initial
Report Date 04/28/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberC-UTLMY-501J-ABRM-HC-FST
Other Device ID NumberN/A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/11/2015
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Device Age21 MO
Event Location Hospital
Initial Date Manufacturer Received 05/14/2015
Initial Date FDA Received05/28/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/24/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-